Ever Supreme Bio Technology Co., Ltd (TPEX: 6712)

Ever Supreme Bio Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	453.93	336.44	353.57	641.1	68.88	32
Short-Term Investments	184.5	998.6	915.99	702.6	346.1	562.1
Cash & Short-Term Investments	638.43	1,335	1,270	1,344	414.98	594.1
Cash Growth	-37.55%	5.16%	-5.52%	223.80%	-30.15%	-25.52%
Accounts Receivable	152.84	100.63	84.94	33.66	15.4	5.31
Other Receivables	4.99	0.46	0.88	29.6	2.24	0.34
Receivables	157.83	101.09	85.82	63.27	17.63	5.65
Inventory	107.79	69.09	88.3	56.77	35.49	14.76
Prepaid Expenses	4.61	7.92	6.29	2.11	10.46	12.85
Other Current Assets	2.32	7.73	5.46	0.92	0.07	0.01
Total Current Assets	910.99	1,521	1,455	1,467	478.63	627.36
Property, Plant & Equipment	55.6	64.81	89.84	125.01	171.24	108
Long-Term Investments	844.33	471.31	376.37	333.27	112.51	98.2
Other Intangible Assets	10.44	10.65	11.95	11.14	9.9	9.17
Long-Term Deferred Tax Assets	11.14	1.71	30.32	78.2	80.56	50.33
Other Long-Term Assets	48.72	6.57	9.72	8.22	5.48	17.7
Total Assets	1,881	2,076	1,974	2,023	858.32	910.76
Accounts Payable	33.87	23.33	29.08	15	5.04	1.16
Accrued Expenses	2.54	1.96	3.98	10.49	3.62	1.41
Current Portion of Leases	4.17	5.4	4.5	11.87	9.87	4.11
Current Income Taxes Payable	39.36	46.76	10.47	21.04	-	-
Current Unearned Revenue	157.69	121.65	89.89	12.22	4.12	2.49
Other Current Liabilities	37.41	32.55	25.82	25.9	17.67	19.77
Total Current Liabilities	275.03	231.64	163.74	96.51	40.32	28.93
Long-Term Leases	1.53	0.5	13.36	22.55	33.34	31.76
Long-Term Deferred Tax Liabilities	-	-	3.59	3.82	0.05	0.39
Other Long-Term Liabilities	23.01	0.82	0.76	1.96	3.86	3.76
Total Liabilities	299.57	232.96	181.45	124.83	77.56	64.85
Common Stock	806.73	733.39	681.4	618.18	562.89	560
Additional Paid-In Capital	551.7	785.91	872.22	1,211	486.55	479.95
Retained Earnings	223.21	323.67	238.51	68.74	-300.86	-194.03
Comprehensive Income & Other	-	-	0.04	-	32.19	-
Shareholders' Equity	1,582	1,843	1,792	1,898	780.76	845.91
Total Liabilities & Equity	1,881	2,076	1,974	2,023	858.32	910.76
Total Debt	5.7	5.9	17.86	34.42	43.21	35.88
Net Cash (Debt)	632.74	1,329	1,252	1,309	371.77	558.22
Net Cash Growth	-37.56%	6.19%	-4.40%	252.18%	-33.40%	-30.01%
Net Cash Per Share	7.82	16.17	15.10	15.81	4.98	7.49
Filing Date Shares Outstanding	80.67	80.67	82.42	82.25	74.9	74.51
Total Common Shares Outstanding	80.67	80.67	82.42	82.25	74.9	74.51
Working Capital	635.97	1,289	1,292	1,370	438.31	598.43
Book Value Per Share	19.61	22.84	21.74	23.07	10.42	11.35
Tangible Book Value	1,571	1,832	1,780	1,887	770.86	836.75
Tangible Book Value Per Share	19.48	22.71	21.60	22.94	10.29	11.23
Machinery	95.39	91.2	85.39	82.64	104.52	61.8
Leasehold Improvements	65.23	65.23	65.23	63.9	63.64	28.87

Source: S&P Capital IQ. Standard template. Financial Sources.